FDA Advisers Recommend More Flu Drug Warnings
A U.S. Food and Drug Administration advisory committee has recommended stronger warning labels for flu drugs sold by Roche Holding AG and GlaxoSmithKline Plc after reports showed an increase in psychotic...To view the full article, register now.
Already a subscriber? Click here to view full article